Union Bancaire Privee UBP SA Boosts Stock Position in Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-22T05:54:33+00:00

Union Bancaire Privee increased its stake in Regeneron Pharmaceuticals by 672.3% to nearly $3 million, despite insider selling. Analysts rate the stock as a "Moderate Buy" with a target price of $802.27 following strong earnings and a raised dividend.

NodeGuardian

2026-03-22 05:54:33

Abstract generation in progress

Union Bancaire Privee UBP SA significantly increased its stake in Regeneron Pharmaceuticals, Inc. by 672.3% in the fourth quarter, bringing its total holdings to 3,993 shares valued at over $3 million. This increase occurred despite recent insider selling and follows Regeneron’s strong quarterly earnings beat and a raised dividend. The company maintains a “Moderate Buy” consensus rating from analysts, with an average target price of $802.27.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes